Growth of the sickle cell disease market is driven by increase in demand for sickle cell disease treatments due to rise in prevalence of sickle cell disease and expansion of R&D pipeline, ongoing medicine approvals, and strong growth potential in unexplored new markets are expected to provide numerous opportunities for the market growth during the forecast period.